These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6120229)

  • 21. Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
    Bhargava HN
    Neuropharmacology; 1983 Dec; 22(12A):1357-61. PubMed ID: 6141535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine influences on the actions of morphine. I. Alteration of target gland hormones.
    Kasson BG; George R
    J Pharmacol Exp Ther; 1983 Feb; 224(2):273-81. PubMed ID: 6681631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Gulden H; Bungart KJ
    Life Sci; 1989; 44(8):555-61. PubMed ID: 2564620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of peptides on the development of tolerance to buprenorphine, a mixed opiate agonist-antagonist analgesic.
    Bhargava HN
    Eur J Pharmacol; 1982 Apr; 79(1-2):117-23. PubMed ID: 7084303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central action of narcotic analgesics. IX. Participation of serotonin in the development of tolerance to cataleptogenic effects of morphine in rats.
    Langwiński R; Fidecka S
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):437-44. PubMed ID: 6460229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ; Wei ET
    Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on GH, LH, prolactin, FSH, and TSH secretion in rats with and without morphine.
    Krowicki ZK; Kastin AJ
    Neuropeptides; 1991 Jan; 18(1):41-7. PubMed ID: 1675454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of amphetamine and nomifensine on the development of morphine tolerance in the test of hypermotility in mice and catalepsy in rats.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(6):503-10. PubMed ID: 6687158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease.
    Voigt KH; Fehm HL; Lang RE; Beinert KE; Pfeiffer EF
    Horm Metab Res; 1977 Mar; 9(2):150-2. PubMed ID: 16818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-Leu-Gly-NH2 serves as a conditioned stimulus in the acquisition of conditioned tolerance.
    McLaughlin CR; Lichtman AH; Fanselow MS; Cramer CP
    Behav Neurosci; 1989 Apr; 103(2):447-51. PubMed ID: 2565116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
    Björkman S; Castensson S; Sievertsson H
    J Med Chem; 1979 Aug; 22(8):931-5. PubMed ID: 40028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat.
    Bhargava HN
    Life Sci; 1981 Jul; 29(1):45-51. PubMed ID: 6115301
    [No Abstract]   [Full Text] [Related]  

  • 36. Drugs that modify opioid tolerance, physical dependence, and abstinence symptoms: preclinical and clinical studies.
    Bhargava HN
    NIDA Res Monogr; 1995; 147():53-83. PubMed ID: 8742781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN
    Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inability of cyclo (LEU-GLY) to facilitate the development of tolerance to and physical dependence on morphine in the rat.
    Bhargava HN
    Life Sci; 1980 Sep; 27(12):1075-81. PubMed ID: 6106875
    [No Abstract]   [Full Text] [Related]  

  • 39. MIF-1 facilitates passive avoidance retention.
    Puciłowski O; Płaźnik A; Kostowski W
    Pol J Pharmacol Pharm; 1982; 34(1-3):107-13. PubMed ID: 6132368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone-like protective effect of MIF-1 (Pro-Leu-Gly-NH2) on hemorrhagic shock.
    Krause W; Nieber K; Ehrlich A; Bienert M; Oehme P
    Pharmazie; 1984 May; 39(5):352-3. PubMed ID: 6147863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.